← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mayo Clinic
Rochester, MN
$378,400,052
Total funding
893
Grants
Funding over time
peak $177.7M · FY2005–25$200M$150M$100M$50M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$287,975,532 · 789
DOD$105,212,387 · 104
NASA$891,870 · 3
DOE$837,700 · 1
USDA$399,995 · 1
HHS (Other)$0 · 1
FDA$0 · 1
By mechanism
R01$173,742,310 · 288
—$107,341,952 · 109
P50$18,691,714 · 35
P01$18,109,423 · 39
U01$17,814,425 · 16
M01$10,681,678 · 248
Investigators at Mayo Clinic
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
General Clinical Research Center$5,710,816
M01 · FY2005 · RR
NORTH CENTRAL CANCER TREATMENT GROUP$5,247,035
U10 · FY2004 · CA
EVALUATION OF THE CARDIAC AND METABOLIC EFFECTS OF SEMAGLUTIDE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION$5,047,034
· FY2022 · Defense Health Agency
Mayo Comprehensive Cancer Center Grant$5,000,000
P30 · FY2004 · CA
GENERAL CLINICAL RESEARCH CENTER$4,970,862
M01 · FY2004 · RR
Mayo Comprehensive Cancer Center Grant$4,970,529
P30 · FY2005 · CA
A PHASE I CLINICAL TRIAL IN OSTEOARTHRITIS GENE THERAPY$4,889,678
· FY2016 · Department of the Army
NORTH CENTRAL CANCER TREATMENT GROUP$4,846,524
U10 · FY2005 · CA
IMPROVED TRAINING METHOD FOR RAPID REHAB OF AMPUTESS$3,186,318
· FY2011 · Department of Defense
IMPROVED TRAINING PROGRAM FOR FALL PREVENTION OF WARFIGHTERS WITH LOWER EXTREMITY TRAUMA$3,145,058
· FY2015 · Department of the Army
POST-TRAUMATIC EPILEPSY: A LONGITUDINAL, POPULATION-BASED MEDICAL RECORD REVIEW ANALYSIS OF INCIDENCE, RISK, AND PREDICTION.$3,100,000
· FY2021 · Defense Health Agency
ASSESSMENT OF HEPATITIS C VIRUS (HCV) INFECTION RELATED CHRONIC LIVER DISEASE WITH ADVANCED MULTIPARAMETRIC MAGNETIC RESONANCE ELASTOGRAPHY (MRE)$2,970,690
· FY2019 · Defense Health Agency
Community Clinical Oncology Program$2,833,894
U10 · FY2005 · CA
Pharmacogenetics of Phase II Drug Metabolizing Enzymes$2,660,531
U01 · FY2005 · GM
Community Clinical Oncology Program$2,566,072
U10 · FY2004 · CA
SPORE in Prostate Cancer$2,555,905
P50 · FY2005 · CA
SPORE in Prostate Cancer$2,476,722
P50 · FY2004 · CA
NKG7-ARMED TUMOR-INFILTRATING LYMPHOCYTE THERAPY FOR METASTATIC UVEAL MELANOMA$2,455,718
· FY2025 · Defense Health Agency
EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM$2,310,000
C06 · FY2004 · RR
Mayo Clinic Breast Cancer SPORE$2,300,000
P50 · FY2005 · CA